CardiotoxicityDoxorubicinHeart
Dr. Kimo C. Stine, MD
NPI1952491516
- Publications
- 53
- Clinical trials
- 8
- Industry payments
- $31,977
- Insurance carriers
- 8
- State licenses
- 3
- Practice address
- 1 Childrens Way, Little Rock, AR 72202
- Practice phone
- Call (501) 364-4374
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Stine's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kimo C. Stine is a pediatric hematology and oncology physician in Little Rock, Arkansas
Dr. Stine practices in Little Rock, Arkansas.
Dr. Stine's NPI, 1952491516, was assigned on October 13, 2006. Dr. Stine graduated from University of Kansas School of Medicine - Kansas City in 1982. Dr. Stine's Arkansas license number on file is N-8125.
NPI and contact details
- NPI
- 1952491516NPI Registry (opens in a new tab)
- NPI enumeration date
- October 13, 2006
- NPI status
- Active
- Practice phone
- (501) 364-4374
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1982
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Kimo C. Stine's practice address is in Little Rock, Arkansas
Dr. Stine's practice address in the NPI Registry is 1 Childrens Way, Little Rock, AR 72202, in Pulaski County. The practice phone is (501) 364-4374.
- NPI Registry address1 Childrens Way, Little Rock, AR 72202 · Pulaski CountyPhone(501) 364-4374
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Kimo C. Stine's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stine practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Stine's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Stine practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kimo C. Stine is one of 14 pediatric hematologys and oncology physicians in Arkansas
Pediatric hematology-oncology is Dr. Stine's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Stine is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Stine's licenses on file in 3 states: Arkansas, North Carolina and Louisiana.
Specialties and state licenses
- Pediatric hematology and oncology, ArkansasPrimary
- North Carolina license
- Louisiana license
Pediatric hematologys and oncology physicians near Dr. Stine
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
14pediatric hematologys and oncology physicians in Arkansas
9pediatric hematologys and oncology physicians in Little Rock
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kimo C. Stine has 53 publications on record
Dmand AI links 53 papers to Dr. Stine, published from 2005 to 2022. 2013 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Hemophilia A and Antineoplastic Agents. Dr. Stine has published most often in Pediatr Blood Cancer. Dr. Stine's most frequent co-authors are Gary V. Dahl, MD, Michael Raymond Jeng, MD and David L. Becton, MD.
Papers53
Years published2005 to 2022
Dr. Stine's papers by year, 2005 to 2022
Topics Dr. Stine writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Hemophilia A
- Antineoplastic Agents
- Doxorubicin
- Infusions, Intravenous
- Leukemia, Myeloid
- Factor VIII
- HIV Infections
Dr. Stine's most frequent co-authors
- Gary V. Dahl, MD3 shared papers
- Michael Raymond Jeng, MD3 shared papers
- David L. Becton, MD2 shared papers
Recent publications by Dr. Stine
J Appl Toxicol
Antibiotics, AntineoplasticCalciumCardiomyopathies
Pediatr Blood Cancer
BenzoatesHydrazinesPlatelet Count
See who Dr. Stine researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Stine works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kimo C. Stine has worked on 8 clinical trials
Dmand AI links Dr. Stine to 8 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Hemophilia A, Coagulation Protein Disorders and Histiocytosis, Langerhans-Cell. Green Cross Corporation sponsors the most, 2.
Clinical trials with Dr. Stine by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- 1Phase 2/3: 1 trial
- 3Phase 3: 3 trials
- 1Phase 4: 1 trial
Conditions in Dr. Stine's trials
- Hemophilia A
- Coagulation Protein Disorders
- Histiocytosis, Langerhans-Cell
- Leukemia
- Lymphoma, Large-Cell, Anaplastic
Investigators on the most trials with Dr. Stine
- Michelle L. Hermiston, MD2 shared trials
- Clara Y. Lo, MD2 shared trials
- Catherine Ellen McGuinn, MD2 shared trials
Recent clinical trials with Dr. Stine
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis (opens in a new tab)
RecruitingPhase 2/3
Histiocytosis, Langerhans-CellHistiocytosis2-chlorodeoxyadenosineCytosine ArabinosideINDOMETHACIN
Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A (opens in a new tab)
Status unknownPhase 3
Hemophilia ACoagulation Protein DisordersGreenGene™ F
Lymphoma, Large-Cell, AnaplasticLymphoma, T-CellBrentuximab VedotinCrizotinibCyclophosphamide
Purpura, Thrombocytopenic, IdiopathicPurpura, ThrombocytopenicSecond Line ITP agents
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A (opens in a new tab)
Status unknownPhase 3
Hemophilia ACoagulation Protein DisordersGreenGene™ FGreenGene™ F and an approved recombinant Factor VIII product
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kimo C. Stine received $31,977 in industry payments from 2016 to 2022
CMS Open Payments shows 32 general payments to Dr. Stine from 12 drug and device companies from 2016 to 2022. Speaker and faculty fees make up the largest share, 59% of the total. BioMarin Pharmaceutical Inc. paid the most, $19,901. It also lists 10 research payments totaling $7,360 from 2020 to 2024.
General payments to Dr. Stine by program year, 2016 to 2022
General payments to Dr. Stine by kind, 2016 to 2022
$32Kin total
- Speaker and faculty fees$18,92059%
- Consulting fees$10,28532%
- Travel and lodging$2,4378%
- Food and beverage$2501%
- Education$840%
Companies that paid Dr. Stine the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Kimo C. Stine graduated from University of Kansas School of Medicine - Kansas City
Dr. Stine graduated from University of Kansas School of Medicine - Kansas City in 1982. Dr. Stine is a member of ASCO, ASH, American Society of Pediatric Hematology Oncology and Histiocytosis Society.
- Medical school
- Board certified in pediatric hematology-oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Kimo C. Stine accepts plans from 8 insurance carriers
Dr. Stine is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Arkansas Blue Cross and Blue Shield. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
- Aetna
- Blue Cross Blue Shield of Michigan
- Arkansas Blue Cross and Blue Shield
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Regence Health Plans
- AR State Medicaid
- SelectHealth
Plan types Dr. Stine accepts, by number of carriers
- PPO6
- Medicare5
- HMO3
- POS3
- EPO1
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Kimo C. Stine's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kimo C. Stine
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kimo C. Stine's NPI number?
Dr. Kimo C. Stine's NPI number is 1952491516. It was assigned on October 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Kimo C. Stine?
Dr. Kimo C. Stine is a pediatric hematology and oncology physician in Little Rock, Arkansas. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Kimo C. Stine practice?
Dr. Stine practices at 1 Childrens Way, Little Rock, AR 72202.
What is Dr. Kimo C. Stine's office phone number?
The practice phone on file for Dr. Stine is (501) 364-4374.
What is Dr. Kimo C. Stine's medical license number?
Dr. Stine's Arkansas license number on file is N-8125, one of the licenses on file in 3 states.
Which states has Dr. Kimo C. Stine been licensed in?
Dmand AI has state licenses on file for Dr. Stine in Arkansas (1991 to 2025), North Carolina (1989 to 1992) and Louisiana (1989 to 1991).
Is Dr. Kimo C. Stine board certified?
Yes. Dr. Stine is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Kimo C. Stine go to medical school?
Dr. Stine graduated from University of Kansas School of Medicine - Kansas City in 1982.
Has Dr. Kimo C. Stine received payments from drug or device companies?
CMS Open Payments shows $31,977 in general payments to Dr. Stine from 12 companies from 2016 to 2022. The largest total came from BioMarin Pharmaceutical Inc.
How long has Dr. Kimo C. Stine been practicing?
Dr. Stine graduated from medical school in 1982, 44 years ago.
Show 3 more questionsShow fewer questions
Does Dr. Kimo C. Stine do research?
Dmand AI links 53 publications to Dr. Stine, published from 2005 to 2022. Dr. Stine has worked on 8 clinical trials.
Who does Dr. Kimo C. Stine publish with?
Dr. Stine's most frequent co-authors are Gary V. Dahl, MD (3 shared papers), Michael Raymond Jeng, MD (3 shared papers) and David L. Becton, MD (2 shared papers).
What insurance does Dr. Kimo C. Stine accept?
Dr. Stine is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Arkansas Blue Cross and Blue Shield. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Arkansas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card